# Hillrom to acquire Bardy Diagnostics for $375M

Hillrom has reached a definitive agreement to acquire Bardy Diagnostics, a provider of ambulatory cardiac monitoring technologies, for $375 million in cash plus potential milestone payments. The deal includes net operating losses valued at over $20 million.

- Type: Acquisition
- Announced: 2021-01-19
- Where: United States
- Value: $375.0M
- Status: announced
- Products: ambulatory cardiac monitoring technologies, Carnation Ambulatory Monitor (CAM patch)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Hillrom](https://endata.com/companies/40245.md) (acquirer)
- [Bardy Diagnostics](https://endata.com/companies/52629.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/hillrom-announces-planned-acquisition-of-bardy-diagnostics-inc-301210529.html), 2021-01-19: "This acquisition provides Hillrom with a highly strategic and differentiated diagnostic cardiology platform aligned with our vision of Advancing Connected Care™."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.